Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Banco de datos
Tipo de estudio
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Prostaglandins Other Lipid Mediat ; 164: 106699, 2023 02.
Artículo en Inglés | MEDLINE | ID: mdl-36513319

RESUMEN

Osteoarthritis (OA) is a common joint disease characterized by the breakdown of subchondral bone and cartilage damage, most often affecting middle-aged and elderly people. Although the etiology of OA is still unknown, some reports suggest that inflammatory factors such as interleukin (IL)- 1ß mediate the progression of OA. To investigate the effect of IL-1ß and the possibility of treatment for OA, we applied 2-carba-cyclic phosphatidic acid (2ccPA) and its derivatives on human chondrocytes. 2ccPA is a synthesized phospholipid derived from a bioactive phospholipid mediator: cyclic phosphatidic acid (cPA). It has been previously reported that 2ccPA exhibits anti-inflammatory and chondroprotective effects in an OA animal model. 2ccPA and its ring-opened body (ROB) derivative significantly suppressed IL-1ß-induced upregulation of IL-6, matrix metalloproteinase-13, and cyclooxygenase-2, as well as the degradation of type II collagen and aggrecan. However, the other two derivatives, namely the deacylated and ring-opened deacylated bodies, showed little effect on an IL-1ß-exposed human chondrosarcoma cell-line. These data suggest that the intactness of 2ccPA and ROB is essential for anti-inflammatory effects on OA. Collectively, this study provides evidence that 2ccPA and ROB would be novel therapeutic agents for OA.


Asunto(s)
Condrocitos , Osteoartritis , Animales , Persona de Mediana Edad , Humanos , Anciano , Condrocitos/metabolismo , Osteoartritis/tratamiento farmacológico , Osteoartritis/metabolismo , Antiinflamatorios/farmacología , Ácidos Fosfatidicos/farmacología , Interleucina-1beta/farmacología , FN-kappa B/metabolismo , Células Cultivadas
2.
J Phys Chem A ; 125(50): 10604-10614, 2021 Dec 23.
Artículo en Inglés | MEDLINE | ID: mdl-34905372

RESUMEN

Theoretical calculations of phosphorescent spectra and nonradiative transition (NRT) rate constants for S1 ⇝ T1, T1 ⇝ S0, and S1 ⇝ S0 were carried out to determine the best candidate for a blue-color phosphorescent complex among several derivatives of bis(2-phenylpyridine)(acetylacetonate)iridium(III). The geometries of the ground state (S0), the lowest triplet state (T1), and the lowest excited singlet state (S1) were optimized at the levels of density functional theory, in which B3LYP functionals and SBKJC+p basis sets were used. The NRT rate constants were derived by using a generating function method within the displaced harmonic oscillator model. The results of the calculation for phosphorescence showed that the introduction of F and/or CN substituents at the 4'/6'-th and 5'-th sites in 2-phenylpyridinate (ppy) ligands, respectively, causes a blue shift of the emission spectra. They also suggest that Ir(5-CN,6-F-ppy)2(acac), denoted 3(56) in the text, is a good candidate for a blue-color phosphorescent complex because a blue shift of emission spectra and a moderate intensity are obtained for phosphorescence and, furthermore, this complex is calculated to have a large rate constant for S1 ⇝ T1 and relatively smaller rate constants for T1 ⇝ S0 and S1 ⇝ S0 based on the calculations of spin-orbit coupling and nonadiabatic coupling constants.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA